NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT00140595,ACVBP Plus Rituximab Versus CHOP Plus Rituximab in Patients With Diffuse Large B-cell Lymphoma and Age-adjusted IPI of 1,https://clinicaltrials.gov/study/NCT00140595,,COMPLETED,This study is a multicentric randomized trial evaluating the efficacy of the combination ACVBP+rituximab compared to the combination of CHOP+rituximab in patients aged from 18 to 59 years with diffuse large B-cell lymphoma and one factor of the age-adjusted international prognostic index (IPI).,NO,Diffuse Large-Cell Lymphoma,DRUG: rituximab|DRUG: doxorubicin|DRUG: cyclophosphamide,"Event-free survival (EFS), events defined as death from any cause, relapse for complete responders (CR) and unconfirmed complete responders (CRu), progression during or after treatment, changes of therapy during allocated treatment.","Response rate at the end of the treatment, progression rate, relapse rate, disease-free survival for complete responders, overall survival, neuromeningeal relapse rate and additional toxicities with ACVBP+rituximab combination",,Lymphoma Study Association,Amgen,ALL,ADULT,PHASE3,380,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,LNH03-2B,2003-12,2009-01,2009-01,2005-09-01,,2011-03-04,"Groupe d'étude des lymphomes de l'adulte, Yvoir, Belgium|Hôpital Henri Mondor, Créteil, 94010, France|Centre Léon Bérard, Lyon, 69008, France|Hôpital Saint Louis, Paris, 75010, France|Hématologie Adultes - Hôpital Necker, Paris, 75743, France|Service d'Hématologie - Centre Hospitalier Lyon-Sud, Pierre-Bénite cedex, 69495, France|Centre Hospitalier Robert Debré, Reims, 51092, France|Centre Henri Becquerel, Rouen, 76038, France|Hématologie CHU Purpan, Toulouse, 31059, France|Institut Gustave Roussy, Villejuif, France",
